These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 12715326)
21. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Dennert R; Velthuis S; Schalla S; Eurlings L; van Suylen RJ; van Paassen P; Tervaert JW; Wolffs P; Goossens VJ; Bruggeman C; Waltenberger J; Crijns HJ; Heymans S Antivir Ther; 2010; 15(2):193-201. PubMed ID: 20386074 [TBL] [Abstract][Full Text] [Related]
22. Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. Frémont M; Metzger K; Rady H; Hulstaert J; De Meirleir K In Vivo; 2009; 23(2):209-13. PubMed ID: 19414405 [TBL] [Abstract][Full Text] [Related]
23. Parvovirus B19 infection after plasma exchange for myasthenia gravis. Bianchi M; Rago I; Zini G; D'Onofrio G; Leone G Lab Hematol; 2007; 13(1):34-8. PubMed ID: 17353182 [TBL] [Abstract][Full Text] [Related]
24. Chronic parvovirus B19 infection leading to red cell aplasia following treatment of Hodgkin lymphoma. Poplar S; Allford S; Rooney N Br J Haematol; 2010 Mar; 148(5):671. PubMed ID: 19681883 [No Abstract] [Full Text] [Related]
25. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia. Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055 [TBL] [Abstract][Full Text] [Related]
26. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688 [TBL] [Abstract][Full Text] [Related]
27. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Crabol Y; Terrier B; Rozenberg F; Pestre V; Legendre C; Hermine O; Montagnier-Petrissans C; Guillevin L; Mouthon L; Clin Infect Dis; 2013 Apr; 56(7):968-77. PubMed ID: 23243178 [TBL] [Abstract][Full Text] [Related]
28. No apparent difference in the prevalence of parvovirus B19 infection between chronic fatigue syndrome patients and healthy controls in Japan. Kato YH; Yamate M; Tsujikawa M; Nishigaki H; Tanaka Y; Yunoki M; Kuratsune H; Watanabe Y; Ikuta K J Clin Virol; 2009 Mar; 44(3):246-7. PubMed ID: 19200778 [No Abstract] [Full Text] [Related]
29. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987 [TBL] [Abstract][Full Text] [Related]
30. Severe ataxia as a complication of human parvovirus B19 acute encephalitis in a child. Greco F; Barbagallo ML; Chiodo DC; Guglielmino R; Sorge G J Child Neurol; 2008 Sep; 23(9):1078-80. PubMed ID: 18487517 [TBL] [Abstract][Full Text] [Related]
31. In vitro erythroid effects of human stem cell factor in a case of human immunodeficiency virus-related chronic parvovirus B19 induced anemia. Liesveld JL; Weissbach NE; Shafer JA; Abboud CN Hematol Pathol; 1993; 7(1):23-32. PubMed ID: 7682213 [TBL] [Abstract][Full Text] [Related]
32. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment. Arzouk N; Snanoudj R; Beauchamp-Nicoud A; Mourad G; Charpentier B; Tchernia G; Durrbach A Transpl Int; 2006 Feb; 19(2):166-9. PubMed ID: 16441366 [TBL] [Abstract][Full Text] [Related]
33. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital]. Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063 [TBL] [Abstract][Full Text] [Related]
34. Parvovirus B19 infection in an isolated pancreas transplant recipient. Onitilo AA; Shaw GR Transplant Proc; 2005 Dec; 37(10):4433-5. PubMed ID: 16387138 [TBL] [Abstract][Full Text] [Related]
35. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection. Corcoran A; Crowley B; Dewhurst C; Pizer BL; Doyle S J Med Virol; 2006 Jan; 78(1):125-8. PubMed ID: 16299723 [TBL] [Abstract][Full Text] [Related]
36. Parvovirus B19: a cause for aplastic crisis and hemophagocytic lymphohistiocytosis. Yilmaz S; Oren H; Demircioğlu F; Firinci F; Korkmaz A; Irken G Pediatr Blood Cancer; 2006 Nov; 47(6):861. PubMed ID: 16514614 [No Abstract] [Full Text] [Related]
37. Persistent parvovirus-associated chronic fatigue treated with high dose intravenous immunoglobulin. McGhee SA; Kaska B; Liebhaber M; Stiehm ER Pediatr Infect Dis J; 2005 Mar; 24(3):272-4. PubMed ID: 15750469 [TBL] [Abstract][Full Text] [Related]
38. Inactivation of parvovirus B19 by liquid heating incorporated in the manufacturing process of human intravenous immunoglobulin preparations. Yunoki M; Urayama T; Tsujikawa M; Sasaki Y; Abe S; Takechi K; Ikuta K Br J Haematol; 2005 Feb; 128(3):401-4. PubMed ID: 15667545 [TBL] [Abstract][Full Text] [Related]
39. An assay for parvovirus B19 neutralizing antibodies based on human hepatocarcinoma cell lines. Caillet-Fauquet P; Di Giambattista M; Draps ML; Hougardy V; de Launoit Y; Laub R Transfusion; 2004 Sep; 44(9):1340-3. PubMed ID: 15318858 [TBL] [Abstract][Full Text] [Related]
40. Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient. Shen Q; Xu H; Cao Q; Zhou LJ; Xu J; Fang XY; Ge J Pediatr Transplant; 2011 Jun; 15(4):E76-9. PubMed ID: 20136725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]